Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
06/2011
06/21/2011CA2460789C Acid amide derivatives, process for their production and pesticides containing them
06/16/2011WO2011071058A1 Preparation method for optically active 2-hydroxycycloalkane carboxylic acid ester
06/15/2011EP2330894A1 Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
06/15/2011CN1700923B Multi-substituted selective androgen receptor modulators and methods of use thereof
06/15/2011CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
06/15/2011CN101080384B Manufacture process of N-substituted salicylamide
06/15/2011CN101080381B Manufacture process of n-substituted salicylamides
06/14/2011US7960436 Therapy and prophylaxis of diseases and disorders such as seizure disorders; [1-Amino-5-(4-trifluoromethyl-phenylamino)-5,6,7,8-tetrahydro-naphthalen-2-yl]-carbamic acid ethyl ester
06/14/2011US7960398 Potent inhibitors of TNF activity
06/14/2011US7960369 Receptor function regulator
06/14/2011CA2425311C Ketone compounds and compositions for cholesterol management and related uses
06/14/2011CA2369591C Disodium salts, monohydrate, and ethanol solvates
06/14/2011CA2338419C Pulmonary delivery of active agents
06/09/2011WO2011067266A1 Carboxylic acid analogs as glycogen synthase activators
06/09/2011US20110136902 12-membered-ring macrolactam derivatives
06/08/2011EP2328863A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
06/07/2011US7956212 Levodopa prodrugs, and compositions and uses thereof
06/07/2011CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
06/07/2011CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors
06/02/2011US20110130448 Functionalized phenolic esters and amides and polymers therefrom
06/02/2011US20110130445 Substituted 3-phenylpropionic acids and the use thereof
06/02/2011US20110129419 In vivo imaging agents
06/01/2011CN102083785A Fluorinated esters
06/01/2011CN102083432A Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/01/2011CN102079700A Method for synthesizing novel tetracyclic diterpene compound from stevioside
05/2011
05/31/2011CA2172282C Chiral surfactants and methods for their use in chiral separations
05/26/2011WO2011061935A1 Process for producing 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative and intermediate thereof
05/26/2011WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
05/26/2011WO2011061154A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives
05/26/2011US20110124726 Novel carboxylic acid derivatives
05/26/2011US20110124664 Polycationic Compounds And Uses Thereof
05/26/2011US20110124648 Glucagon receptor antagonists, preparation and therapeutic uses
05/25/2011EP2323971A1 Salicylamide derivatives as nicotinic alpha 7 modulators
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102070482A Derivatives of natural product S6-2, and preparation method and use thereof as anti-tumor medicines
05/25/2011CN102070481A Medicine tromantadine with adamantane structure, anti-tumor application of derivates and analogs thereof having new indications
05/25/2011CN101023056B Levodopa prodrugs, and compositions and uses thereof
05/24/2011US7947851 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
05/24/2011US7947740 Bimatoprost crystalline form I
05/24/2011US7947704 2,4,6-phenyl-substituted cyclic ketoenols
05/24/2011CA2499690C Diaryl ethers as opioid receptor antagonist
05/24/2011CA2464807C Phenyl-propargylether derivatives
05/24/2011CA2431822C Blocked polyisocyanates
05/19/2011WO2011058154A1 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
05/19/2011US20110118476 Process for Preparing Chiral Compounds
05/19/2011US20110118352 Oat extracts: refining, compositions and methods of use
05/19/2011US20110118347 TREATMENT Of RINGWORM
05/19/2011US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
05/19/2011US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
05/18/2011EP2322501A1 4-dedimethylamino tetracycline compounds
05/18/2011EP2321260A2 Improved process for the production of bimatoprost
05/18/2011EP2320897A1 Compositions and methods of treating amyloid disease
05/18/2011EP1698618B1 Benzamide derivative
05/18/2011EP1318140B1 Novel amide derivatives and medicinal use thereof
05/18/2011EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
05/18/2011CN102060809A Rhein derivatives and preparation and application thereof
05/18/2011CN102059145A Catalyst, method for synthesizing (S)-octopamine and method for synthesizing (S)-N-trans-feruloyloctopamine
05/17/2011CA2411409C Vitamin d derivatives
05/12/2011WO2011054616A1 Processes for the preparation of substituted anilines
05/12/2011US20110112187 Use Of Tranilast And Derivatives Thereof For The Therapy Of Neurological Conditions
05/12/2011CA2780149A1 Ire-1.alpha. inhibitors
05/11/2011EP2318357A2 Fluorinated ether compounds and methods of using the same
05/11/2011CN1665801B Anti tubercular drug: compositions and methods
05/11/2011CN102056893A Ether-amide type compounds, preparation method and uses
05/11/2011CN102050817A Synthetic method of N-(4-oxo-6-X-1H-benzofuran-2-tetrazole)-4-phenylbutoxy benzamide
05/11/2011CN102050759A Resveratrol amide derivative and preparation method thereof
05/11/2011CN102050758A Novel amide derivatives and medicinal use thereof
05/11/2011CN102050720A Novel DHA derivative and its usage as medicine
05/11/2011CN101072561B Diaminoalkane aspartic protease inhibitors
05/10/2011US7939689 Short-acting sedative hypnotic agents for anesthesia and sedation
05/10/2011US7939562 fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ionic groups
05/10/2011CA2478335C Amino-methyl substituted tetracycline compounds
05/05/2011WO2011053948A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
05/05/2011WO2011052388A1 Iodobenzene derivative and process for preparation of optically active spirolactone compound using same
05/05/2011WO2011051375A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
05/05/2011US20110105773 Production method of (2e,6z,8e)-n-isobutyl-2,6,8-decatrienamide (spilanthol), and food or drink, fragrance or cosmetic, or pharmaceutical comprising the same
05/05/2011US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
05/05/2011US20110105571 Opioid Receptor Antagonists
05/05/2011CA2779268A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
05/04/2011EP2316820A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
05/04/2011EP2316450A1 Amino-methyl substituted tetracycline compounds
05/04/2011EP2315740A1 Fatty acid acetylated salicylates and their uses
05/04/2011CN102046577A Method for producing aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxylic acid amides
05/04/2011CN102040618A Preparation method and relevant intermediate of PGF2a analogue
05/04/2011CN102040538A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate
05/04/2011CN102040537A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate
05/04/2011CN102040536A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate
05/04/2011CN102040535A Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
05/04/2011CN102040534A Self-assembled nanostructures
05/03/2011CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids
05/03/2011CA2438848C Compositions for delivering bisphosphonates
05/03/2011CA2174961C Desferrioxamine oral delivery system
04/2011
04/28/2011WO2011048314A1 Ether-amide compounds and uses thereof
04/28/2011WO2011014009A3 Novel di-substituted phenoxyacetyl-based compound or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for suppressing multiple drug resistance comprising same as an active ingredient
04/28/2011WO2011008675A3 Catecholamine compounds, compositions, and formulations, and methods of using the same
04/28/2011WO2009019616A3 Isoprekinamycin analogs and syntheses thereof
04/28/2011US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
04/27/2011EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
04/27/2011EP2313386A1 Synthesis routes to 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
04/26/2011US7932416 Prepared by electrophilic aromatic substitution via halogenation, chlorosulfonation or nitration of a pentafluorosulfanylbenzene; 2-Methyl-5-nitro-4-pentafluorosulfuranylbenzoic acid; for liquid crystals, polymers, pesticides, herbicides, fungicides, nematocides, parasiticides, insecticides, acaricides
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 157